Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-001279

Chief Scientific Officer acquired 236,331 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2025-12-31 Grant or award +121,331 1,314,664 D: show line 1 in the form
Kidron Miriam Chief Scientific Officer 2025-12-31 Grant or award +115,000 1,429,664 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kidron Miriam Chief Scientific Officer 2025-12-31 Grant or award · Performance Stock Units +19,000 19,000 D: show line 3 in the form
Loading xslF345X05/ownership.xml…